Historical record - last NADAC effective date: 6/19/2024
Product Information
MUCINEX FAST-MAX COLD-FLU CPLT is a brand product labeled by RB Health (US) LLC, priced at $0.6118 per EA under NDC 63824057521. Its NADAC has been published 20 times since Feb 21, 2024.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
MUCINEX FAST-MAX COLD-FLU CPLT
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine HydrochlorideStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
RB Health (US) LLCNDC
63824057521
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/28/2018
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX FAST-MAX COLD-FLU CPLT has been published 20 times since Feb 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6118 per EA |
|---|---|
| All-time high | $0.6183 (Jun 12, 2024) |
| All-time low | $0.6034 (Feb 21, 2024) |
| Median price | $0.6034 |
| Average price | $0.6076 |
| Largest weekly change | +2.5% (May 22, 2024) |
| Weeks tracked | 20 |
| Tracking since | Feb 21, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+1.4%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MUCINEX FAST-MAX COLD-FLU CPLT?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX COLD-FLU CPLT, manufactured by RB Health (US) LLC, is $0.6118 per EA (NDC 63824057521), effective Jul 3, 2024.
How has the price of MUCINEX FAST-MAX COLD-FLU CPLT changed over time?
Over the history we have for it, the NADAC for MUCINEX FAST-MAX COLD-FLU CPLT has held within roughly two percent of its current level. It has been tracked across 20 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX COLD-FLU CPLT?
Since Feb 21, 2024, the NADAC for MUCINEX FAST-MAX COLD-FLU CPLT has ranged from a low of $0.6034 (Feb 21, 2024) to a high of $0.6183 (Jun 12, 2024), with a median of $0.6034 per EA.
Are there cheaper alternatives to MUCINEX FAST-MAX COLD-FLU CPLT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MUCINEX FAST-MAX COLD-FLU CPLT, is $0.5594 per EA — about 9% below MUCINEX FAST-MAX COLD-FLU CPLT.
Who manufactures MUCINEX FAST-MAX COLD-FLU CPLT?
MUCINEX FAST-MAX COLD-FLU CPLT (NDC 63824057521) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.